In particular, it was observed that the Nur77 regulator suppressed acute and chronic liver inflammation in obese animals but also ameliorated nonalcoholic fatty liver disease (NAFLD) by reducing lipid synthesis while enhancing anti-inflammatory and antioxidative status [34]. Here, NR4A1 is linked to metabolic dysfunction-associated steatotic liver disease.